Illumina (ILMN)
Illumina Cash and ST Investments: 1.266B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ILMN Cash and ST Investments Rankings
| Overall | 90th percentile | 421 of 4371 |
| Sector | 93rd percentile | 32 of 504 in Healthcare |
| Industry | 96th percentile | 5 of 160 in Biotechnology |
ILMN Cash and ST Investments Range, Past 5 Years
| Minimum | 275.30M | Mar 2008 |
| Maximum | 1.266B | Mar 2012 |
| Average | 750.11M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these ILMN related companies
ILMN News
Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June
May 30, 6:30AM Business Wire
May 30, 6:30AM Business Wire
Queensland Centre for Medical Genomics Adopts Illumina Sequencing for Australian ICGC Program
May 29, 6:30AM Business Wire
May 29, 6:30AM Business Wire
$GNOM and peers rallying despite lack of news, says Mizuho. $LIFE $ILMN http://stks.co/3zcz
about 5 days ago by abubnic
about 5 days ago by abubnic
genomics have been running for awhile now since $HGSI news and now $ROSG. $ILMN denied Roche buyout but who r next most likely targets?
about 5 days ago by epime7heus
about 5 days ago by epime7heus
$ROSG vol. surges for 4th straight trading day after Medicare coverage approval for its cancer test. $GNOM $LIFE $ILMN http://stks.co/3vQM
about 9 days ago by EPS_MomentuM
about 9 days ago by EPS_MomentuM
$SQNM 2nd payor contract ! - more to come - and 5.4% stake of COHEN FUND from 13G wow could be a big green day ahead $$ $ILMN $GNOM $LIFE
about 21 days ago by biotech
about 21 days ago by biotech
$SQNM 1 competitor down: $NVS : Fluidigm, Novartis End Pact Aimed at Non-invasive Fetal Diagnostic Test $ILMN $GNOM
about 23 days ago by biotech
about 23 days ago by biotech
$ILMN Credit Suisse Near-Term Clouds Clearing-Sunnier Days Ahead- Upgrade to Outperform- $55 TP watch $SQNM on that too!
about 23 days ago by biotech
about 23 days ago by biotech
$ILMN Credit Suisse Near-Term Clouds Clearing-Sunnier Days
Ahead- Upgrade to Outperform- $55 TP
about 23 days ago by biotech
about 23 days ago by biotech
@traderjon beers, girls, and anything else on me in Philly if $EDS goes to mid 3's or higher and $CELG and $ILMN both pop tomorrow
about 26 days ago by epime7heus
about 26 days ago by epime7heus
Biotech targets fight back as Big Pharma circles. $GSK $BMY $PFE $HGSI $AMLN $ONXX $ILMN $AZN http://stks.co/3dnZ
about 27 days ago by abubnic
about 27 days ago by abubnic
Illumina to Webcast Live Presentations at Upcoming Investment Conferences in May
May 02, 6:30AM Business Wire
May 02, 6:30AM Business Wire
RS Losers (20in5) $NIHD $ILMN $CHRW $HUM $NOV $TXT $UPS $STUDY http://chart.ly/nt53fwi
about 29 days ago by gtlackey
about 29 days ago by gtlackey
RS Losers (20in5) $NIHD $NFLX $ILMN $AET $AKAM $EMC $DOW $STUDY http://chart.ly/a98qepv
about 30 days ago by gtlackey
about 30 days ago by gtlackey
$SQNM Lifecodexx video http://stks.co/3Zmq DW TV $GPRO $ILMN $LIFE $GNOM
about 30 days ago by biotech
about 30 days ago by biotech
$HOLX Hologic to Acquire Gen-Probe $GPRO - $SQNM could be bought out next i guess $ILMN ROCHE ?
about 30 days ago by biotech
about 30 days ago by biotech
RT @natesadeghi: $AMLN talking about an ex-US partner as though that's definitely the plan.// Roche should b/o, stead of hostile on $ILMN
about 34 days ago by QR_Winner
about 34 days ago by QR_Winner
UBS Maintains a 'Neutral' on Illumina (ILMN); Drama Takes Backseat, Results Slightly Better Than Expected
Apr 24, 10:52AM Street Insider
Apr 24, 10:52AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ILMN | 44.07 | -0.13 | -0.29% | 5.448B |
| ILF | 40.12 | -0.67 | -1.64% | |
| IL | 4.07 | -0.14 | -3.33% | 230.50M |
| MCD | 89.91 | -0.99 | -1.09% | 92.59B |
| MCBF | 1.15 | -0.09 | -7.26% | 2.358M |
| MCBC | 3.278 | +0.03 | +0.85% | 88.76M |
| MCA | 15.72 | +0.07 | +0.45% | |
| MBWM | 14.75 | -0.07 | -0.47% | 126.85M |
| MBVT | 26.27 | -0.08 | -0.30% | 164.42M |
| MBT | 16.76 | -0.83 | -4.72% |